Areas of Concentration
Practice Contact
Corporate/Securities Law Attorneys
- Ron Berenblat
- David Breyer
- Ryan Busch
- Kuang-Chu (K.C.) Chiang
- Martin Cooper
- John Corrado
- Eduardo Cukier
- Joseph Del Vicario
- Claudia Dubón
- Ian Engoron
- Spencer Feldman
- Joseph Ferrone
- Dakota Forsyth
- Andrew Freedman
- Zachary Freedman
- Robert Friedman
- Robert Frome
- Robert Gagne
- Rachel Gold
- Elizabeth Gonzalez-Sussman
- Nikoleta Holevas
- Mark Kiley
- Kenneth Mantel
- Sasson Marcus
- Jack Meara
- Ryan Nebel
- Michael Neidell
- Joshua Park
- Richard Quatrano
- Mitchell Raab
- Meagan Reda
- Brian Roe
- Victor Rosenzweig
- Jason Saltsberg
- Kenneth Schlesinger
- Kenneth Silverman
- Dorothy Sluszka
- Matthew Traylor
- Rebecca Van Derlaske
- Steve Wolosky
- Honghui Yu
- Cindy Zhang
Our attorneys often serve as “general counsel” to our clients, advising on corporate governance, legal compliance, including SEC regulatory and stock exchange listing requirements, risk management and day-to-day business operations. Our attorneys also structure and negotiate a wide variety of corporate, strategic and financing transactions, including:
- initial public offerings (IPOs), including SPACs, Regulation A offerings, at-the-market offerings (ATMs), rights offerings, private investments in public equity transactions (PIPEs) and other private placements
- credit facilities, debt securities offerings and other debt-financing transactions
- spinoffs, split-ups and tender and exchange offers
- mergers and acquisitions (including private equity, management buyouts and “going private” transactions, whether negotiated or unsolicited)
- venture capital financings (including crowdfunding transactions)
- emerging company matters
- succession planning
- joint ventures
Our corporate attorneys routinely collaborate with colleagues, including attorneys in our Tax, Real Estate, Employment, Employee Benefits, Intellectual Property and Bankruptcy & Financial Restructuring practice groups, to address the complex legal issues related to these transactions and to our clients’ daily operations. As our clients operate nationally and internationally, our corporate securities attorneys regularly work with firms throughout and outside the United States to achieve our clients' objectives.
Public Companies
Leveraging our experience in regulatory compliance, corporate governance and federal and state securities law, we serve as general and special counsel for a large and diverse group of companies with securities listed on the New York Stock Exchange (NYSE), NYSE Amex and Nasdaq markets. Ranging from national and multinational businesses to small and middle-market issuers, our clients depend on us to help them navigate the complexities of Securities and Exchange Commission (SEC) reporting requirements, corporate governance guidelines, general disclosure compliance and other related matters.
Privately Held Companies
Our corporate attorneys also represent entrepreneurs and the executive management of closely held companies as they start up, operate and sell or merge their businesses. We frequently serve as general counsel during negotiations with venture capitalists, private equity investors and merger and acquisition candidates, and advise clients regularly with respect to governance matters and their day-to-day business.
Investors
We advise private equity investors, venture capitalists, private equity fund sponsors, fundless sponsors, high net worth individuals and other investors in a wide variety of private and public equity and debt transactions.
Our Team
Our corporate attorneys are nationally recognized by client and peer-reviewed rating groups such as Chambers USA, The Legal 500 United States, The Best Lawyers in America and Super Lawyers for their abilities and effectiveness in corporate law. The firm's Corporate/Securities Law practice has been recognized as a "Best Law Firm" by U.S. News-Best Lawyers "Tier 1" Nationally and in New York City Metropolitan.
Our team of more than 40 skilled corporate lawyers brings its talents to every legal matter it handles. Together, our expertise spans a diverse range of corporate law matters, from negotiating and drafting stockholder agreements to SEC reporting compliance. Find out more about what we can do for you by contacting Olshan today.
Olshan's Corporate/Securities Law Group represents public and private issuers, underwriters and investors, including hedge funds, venture capital firms and high net worth individuals. The Corporate Group's representation of issuers includes serving as general and special counsel for a large and diverse group of public companies listed on the NYSE, NYSE Amex exchanges and Nasdaq Global Select, Global and Capital Markets. Olshan's Corporate Lawyers are also among the nation's leading experts in shareholder activism and proxy fights.
Olshan acted as counsel to Star Equity Holdings, Inc. in connection with a $14,250,000 registered underwritten public offering of common stock and warrants. Star Equity intends to use the net proceeds from this offering to pursue organic growth initiatives and fund potential acquisitions, and for working capital and other general corporate purposes. Star Equity is a diversified multi-industry holding company that currently operates primarily in the healthcare and construction business sectors. Maxim Group LLC served as the sole book-running manager for the offering.
Olshan acted as counsel to Ault Disruptive Technologies Corporation in its $115 million initial public offering of units (consisting of common stock and warrants), which are now trading on the NYSE American exchange. Ault Disruptive Technologies is a blank-check special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses with a focus on emerging technologies. A.G.P./Alliance Global Partners served as sole book-running manager and Brookline Capital Markets served as co-manager for the offering.
Represented PLx Pharma Inc., a late-stage specialty pharmaceutical company, in its underwritten registered public offering of shares of common stock, worth approximately $71 million, on the Nasdaq Capital Market. PLx Pharma plans to use the net proceeds from the offering for general corporate purposes, including potential additions to working capital and capital expenditures, which also includes launching its new and recently FDA approved drug Vazalore, the first-ever liquid-filled aspirin capsule.
Repesented GlobalSCAPE, Inc. in its acquisition through a public tender offer by Help/Systems, LLC in 2020, representing aggregate consideration over $200 million (including repayment of indebtedness).
Olshan client PowerFleet, Inc., a global leader and provider of subscription-based wireless IoT and M2M solutions for securing, controlling, tracking, and managing high-value enterprise assets, launched a $25 million at-the-market offering with Canaccord Genuity LLC acting as sales agent.
Olshan represented I.D. Systems in its $140 million cash and stock acquisition of Pointer Telocation Ltd., an Israeli public company, and reorganization pursuant to which I.D. Systems and Pointer became wholly-owned subsidiaries of PowerFleet, Inc., a new public holding company dual-listed on the Nasdaq Global Market and the Tel Aviv Stock Exchange. In connection with the financing of the transaction, we also represented PowerFleet in a $55 million convertible note and preferred stock investment with affiliates of Abry Partners II.
Olshan was honored at The Deal Middle Market Awards in Chicago for its work in representing George Feldenkreis, founder and former Executive Chairman of Perry Ellis International, in his deal to take Perry Ellis private, which was honored as the “Deal of the Year” and “Middle Market Activist Campaign of the Year.”
Olshan Frome Wolosky acted as counsel to IMAC Holdings, Inc. in the underwritten initial public offering of IMAC’s shares of common stock and warrants to purchase common stock, at a public offering price of $5.125 per unit. IMAC owns and manages outpatient medical clinics throughout the Midwest that provide regenerative, orthopedic and minimally invasive procedures and therapies centered around treating sports injuries. IMAC has partnered with several active and former professional athletes, opening two Ozzie Smith IMAC Regeneration Centers, two David Price IMAC Regeneration Centers, and a Tony Delk IMAC Regeneration Center. Dawson James Securities, Inc. acted as the book running manager and Axiom Capital Management, Inc. and The Benchmark Company LLC acted as co-managers for the offering. IMAC’s shares and warrants are trading on The NASDAQ Capital Market under the ticker symbols “IMAC” and IMACW.”
Olshan Frome Wolosky acted as counsel to Legacy Housing Corporation in the initial public offering of an aggregate of 4,000,000 shares of its common stock at a public offering price of $12.00 per share. Legacy Housing is the fourth largest producer of manufactured homes in the United States and a recognized leader and innovator in the manufactured housing industry. Shares of the company are trading on The NASDAQ Global Select Market under the symbol “LEGH.” The offering was made through an underwriting group led by B. Riley FBR, Inc., Oak Ridge Financial and National Securities Corporation.
Represented Global Sources Ltd., in its acquisition by, and immediate spin-off from, Fairchild Corporation, a foreign private issuer. Global Sources Ltd. trades on Nasdaq.
In one of the biggest financing deals of 2014, Olshan represented the purchaser of the iconic Mobil Building at 150 East 42nd Street, including securing a $700 million loan from Morgan Stanley Mortgage Capital Holdings to complete their acquisition of the leasehold position. The deal included a 99-year ground lease extension with the land owner, purchasing the existing leasehold from Hiro Real Estate, and creating a sub-leasehold condominium to accommodate Mt. Sinai Medical Center. Several Olshan practice groups represented the buyers in the transaction: Tax & Planning, Real Estate and Corporate/Securities. News reports may be found at The Real Deal and GlobeSt.com.
Represented GenCorp Inc., a leading manufacturer of aerospace and defense products, in connection with an amended and restated $300 million credit facility. The new credit facility amends and restates the Company's prior credit agreement and, among other things, (i) extending the maturity date; and (ii) replacing the existing revolving credit facility and credit-linked facility with (x) a revolving credit facility in an aggregate principal amount of up to $200.0 million (with a $100.0 million subfacility for standby letters of credit and a $5.0 million subfacility for swingline loans) and (y) a term loan facility in an aggregate principal amount of up to $100.0 million.
Represented GenCorp Inc., a leading manufacturer of aerospace and defense products, in connection with a $100 million subordinated credit facility, to be used for a variety of purposes.
Represented Quinpario Acquisition Corp. (Nasdaq:QPAC) (Nasdaq:QPACU) (Nasdaq:QPACW) in its definitive agreement to acquire Jason Incorporated from Saw Mill Capital LLC, Falcon Investment Advisors, LLC and other investors. The purchase price of $538.65 million will be funded by the cash proceeds from QPAC's initial public offering, new debt and rollover equity invested by the current owners and management of Jason.
Represented IZEA, Inc. (Nasdaq: IZEA), an Orlando, Florida based social media sponsorship company, in its completion of a $12 million PIPE financing transaction of common stock and warrants; its largest financing to date. The round was led by Special Situations Funds with participation by IZEA board members, IZEA's CEO and numerous institutional investors.
Represented Roth Capital Partners and Monarch Capital Group, the underwriters of a public offering of 1,100,000 shares of common stock of Pioneer Power Solutions, Inc., a manufacturer of specialty electrical transmission and distribution equipment. It will begin trading on the Nasdaq Capital Market under the symbol "PPSI." Pioneer intends to use the proceeds of this offering to repay its outstanding borrowings with Bank of Montreal, with the remaining balance to be used to fund acquisitions and working capital.
Represented GlobalOptions Group, Inc. in its merger with Walker Digital, LLC, which will do business as PatentProperties, Inc. In connection with the merger, the company also completed an $11.6 million PIPE offering of common stock and warrants.
Represented GenCorp Inc., a leading technology-based designer, developer and manufacturer of aerospace and defense products, in the successful completion of the $550 million acquisition of the Pratt & Whitney Rocketdyne business from United Technologies in part with the proceeds from a $460 million bond offering. The acquisition will nearly double the size of GenCorp and help ensure that it continues to be a leader in the next space age.
Represented CERTPOINT Systems Inc., a provider of SaaS-based learning management software (LMS) and learning content management software (LCMS), in a merger with Infor Inc., a leading global provider of business application software serving more than 70,000 customers.
Represented Ramius V&O Acquisition LLC, a wholly-owned subsidiary of Ramius Value and Opportunity Advisors LLC, in connection with its acquisition, together with Royal Pharma, of Cypress Bioscience, Inc. (NASDAQ:CYPB), a pharmaceutical company engaged in the development of innovative drugs to treat central nervous system (CNS) disorders.
Represented GenCorp Inc. (NYSE:GY), a leading manufacturer of aerospace and defense products, in connection with its amended and restated $200 million credit facility. The new credit facility amended and restated GenCorp’s prior credit agreement to, among other things, extend the maturity date and replace the existing revolving credit facility and credit-linked facility with a revolving credit facility in an aggregate principal amount of up to $150 million and a term loan facility in an aggregate principal amount of up to $50 million. The credit facility is collateralized by a substantial portion of GenCorp’s tangible and intangible personal property and other assets, including the stock and assets of its material domestic subsidiaries that are guarantors of the facility.
Represented Landry’s, Inc. in its acquisition in December 2011 through a two-step merger (tender offer with back-end merger) with McCormick & Schmick’s Seafood Restaurants, Inc. (NASDAQ:MSSR) for a total equity value of approximately $131.6 million. The acquisition was the culmination of a process that began with a proxy contest followed by a seven-month auction process. The transaction was financed through a combination of cash and debt. In April 2011, McCormick & Schmick’s rejected Landry’s initial acquisition offer and implemented a defensive “poison pill.” Our Activist Practice Group quickly formulated a strategy that pressured the McCormick & Schmick’s board to either negotiate a transaction with Landry’s or conduct a sale process for the company. The Activist Practice Group navigated Landry’s through a complex and unprecedented "withhold quorum" proxy campaign. Just two weeks after the commencement of this campaign, McCormick & Schmick’s announced its decision to put itself up for sale. Landry’s participated in the sale process and ultimately signed a merger agreement to acquire McCormick & Schmick’s in October 2011.
Represented Randa Accessories Leather Goods LLC, a privately held men's accessories company, in the $57.3 million acquisition of Swank, Inc. (PINK:SNKI), a leading designer and marketer of men's and women's belts and men's leather accessories, jewelry and suspenders. In connection with the acquisition, we represented Randa in obtaining financing from JPMorgan Chase.
Represented Ness Technologies, Inc. (NASDAQ: NSTC and TASE: NSTC), a global provider of IT services and solutions, in connection with its acquisition by an affiliate of Citi Venture Capital International, a global private equity investment fund, in a transaction valued at approximately $307 million. Ness’s stockholders received $7.75 per share in cash for each share of common stock they held, representing a premium of 17.6% over the closing price of the company’s shares on the last trading day prior to the announcement of the merger agreement, or 22.2% over the average closing price of the company’s shares over the 30 trading days prior to the announcement. The merger provided for Ness’s senior management team to continue in their roles.
Represented Lone Star Steakhouse & Saloon, Inc., a Nasdaq-listed operator of casual and upscale restaurants, in the negotiation of a complex merger with a large private equity firm. In the face of opposition by a significant activist stockholder, we assisted our client in waging a campaign that ultimately secured stockholder approval of the transaction.
Represented United Capital Corp.(NYSE Amex: AFP) in connection with its tender offer to purchase approximately 31% of its outstanding shares at a purchase price that included an approximately 20% premium per share (or an aggregate purchase price of approximately $101 million). In connection with the tender offer, United Capital Corp. also delisted from the NYSE Amex and deregistered from the reporting obligations of the Securities Exchange Act of 1934, as amended.
Represented Pharmacyclics, Inc. (NASDAQ: PCYC), a clinical-stage biopharmaceutical company, in connection with a $57.4 million registered direct offering of its common stock. Pharmacyclics entered into stock purchase agreements with various institutional investors and its CEO for the sale of approximately 6.5 million shares of its common stock at $8.85 per share. Pharmacyclics intended to use the proceeds of the transaction for general corporate purposes, including clinical trials, preclinical research expenses, general and administrative expenses and for working capital. The securities were offered by Pharmacyclics pursuant to an effective shelf registration statement and a registration statement filed pursuant to Rule 462(b) promulgated under the Securities Act.
Represented CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of cardiorenal disease, in connection with its initial public offering and related listing on NYSE Amex. CorMedix sold 1,925,000 units at $6.50 per unit (before underwriting discounts and commissions). Each unit consisted of two shares of CorMedix common stock and a warrant to purchase one share of common stock at a price of $3.4375.
Media Mentions/News
- May 16, 2023
- May 1, 2023
- April 25, 2023
- March 27, 2023
- March 27, 2023
- March 23, 2023
- March 16, 2023
- March 13, 2023
- February 27, 2023
- November 29, 2022
- November 28, 2022
- November 22, 2022
- November 3, 2022
- October 25, 2022
- October 11, 2022
- October 7, 2022
- September 29, 2022
- September 27, 2022
- September 27, 2022
- August 26, 2022
- August 18, 2022
- July 12, 2022
- June 23, 2022
- June 22, 2022
- March 16, 2022
- March 11, 2022
- February 8, 2022
- January 26, 2022
- January 25, 2022
- January 19, 2022
- December 29, 2021
- December 23, 2021
- December 23, 2021
- December 15, 2021
- December 1, 2021
- November 15, 2021
- November 15, 2021
- November 5, 2021
- November 4, 2021
- November 1, 2021
- October 26, 2021
- October 26, 2021
- October 1, 2021
- September 30, 2021
- August 19, 2021
- August 19, 2021
- June 29, 2021
- June 21, 2021
- June 16, 2021
- May 13, 2021
- April 23, 2021
- April 13, 2021
- April 8, 2021
- April 5, 2021
- March 23, 2021
- March 17, 2021
- March 15, 2021
- March 2, 2021
- Honghui Yu and Zachary Freedman Represent PowerFleet in Underwritten Public Offering of Common StockFebruary 4, 2021
- February 2, 2021
- January 12, 2021
- January 12, 2021
- January 6, 2021
- January 6, 2021
- January 5, 2021
- November 6, 2020
- November 5, 2020
- October 28, 2020
- October 21, 2020
- September 23, 2020
- September 14, 2020
- August 20, 2020
- July 29, 2020
- July 22, 2020
- July 20, 2020
- July 20, 2020
- June 16, 2020
- June 1, 2020
- May 18, 2020
- May 18, 2020
- May 12, 2020
- April 17, 2020
- March 27, 2020
- March 3, 2020
- February 28, 2020
- January 28, 2020
- January 10, 2020
- January 8, 2020
- December 27, 2019
- December 16, 2019
- November 20, 2019
- November 15, 2019
- November 5, 2019
- November 1, 2019
- October 22, 2019
- October 18, 2019
- October 14, 2019
- October 4, 2019
- September 12, 2019
- August 26, 2019
- August 15, 2019
- July 22, 2019
- June 24, 2019
- May 17, 2019
- May 13, 2019
- April 30, 2019
- April 2, 2019
- March 5, 2019
- February 19, 2019
- January 9, 2019
- January 3, 2019
- January 2, 2019
- December 21, 2018
- December 20, 2018
- November 9, 2018
- November 8, 2018
- November 1, 2018
- November 1, 2018
- October 26, 2018
- October 23, 2018
- October 9, 2018
- September 19, 2018
- August 24, 2018
- August 24, 2018
- August 20, 2018
- August 15, 2018
- August 14, 2018
- August 8, 2018
- July 30, 2018
- July 2, 2018
- June 20, 2018
- June 5, 2018
- May 17, 2018
- April 10, 2018
- April 4, 2018
- March 30, 2018
- March 2, 2018
- March 1, 2018
- February 26, 2018
- January 26, 2018
- December 22, 2017
- December 19, 2017
- December 13, 2017
- December 13, 2017
- November 22, 2017
- November 17, 2017
- November 2, 2017
- November 1, 2017
- September 25, 2017
- September 20, 2017
- August 30, 2017
- August 15, 2017
- August 15, 2017
- August 4, 2017
- August 2, 2017
- June 30, 2017
- May 22, 2017
- April 5, 2017
- March 30, 2017
- March 15, 2017
- March 2, 2017
- February 8, 2017
- February 7, 2017
- January 18, 2017
- January 11, 2017
- December 30, 2016
- December 30, 2016
- December 14, 2016
- December 7, 2016
- December 5, 2016
- November 9, 2016
- November 1, 2016
- October 25, 2016
- October 19, 2016
- October 7, 2016
- September 21, 2016
- September 19, 2016
- August 15, 2016
- August 3, 2016
- July 29, 2016
- July 21, 2016
- July 6, 2016
- July 1, 2016
- June 27, 2016
- June 20, 2016
- June 2, 2016
- May 23, 2016
- May 3, 2016
- April 26, 2016
- April 25, 2016
- April 8, 2016
- March 14, 2016
- March 6, 2016
- February 25, 2016
- February 19, 2016
- February 19, 2016
- February 18, 2016
- February 11, 2016
- January 29, 2016
- January 27, 2016
- January 21, 2016
- January 15, 2016
- January 15, 2016
- January 11, 2016
- January 6, 2016
- November 30, 2015
- November 21, 2015
- November 21, 2015
- November 3, 2015
- November 2, 2015
- October 15, 2015
- September 30, 2015
- September 30, 2015
- September 30, 2015
- September 16, 2015
- August 3, 2015
- July 15, 2015
- June 19, 2015
- June 3, 2015
- June 1, 2015
- May 27, 2015
- May 20, 2015
- May 19, 2015
- May 6, 2015
- March 23, 2015
- March 23, 2015
- March 12, 2015
- March 4, 2015
- March 4, 2015
- December 3, 2014
- November 17, 2014
- November 3, 2014
- October 29, 2014
- September 30, 2014
- September 24, 2014
- September 24, 2014
- September 17, 2014
- September 9, 2014
- September 2, 2014
- August 29, 2014
- July 14, 2014
- July 2, 2014
- July 2, 2014
- July 1, 2014
- June 5, 2014
- June 3, 2014
- June 2, 2014
- May 21, 2014
- April 21, 2014
- April 21, 2014
- April 17, 2014
- March 17, 2014
- February 28, 2014
- February 24, 2014
- February 10, 2014
- February 10, 2014
- February 5, 2014
- February 3, 2014
- December 24, 2013
- December 17, 2013
- Olshan Represents Food Technology Service, Inc. in $7.23 per Share Sale to Sterigenics InternationalDecember 6, 2013
- December 2, 2013
- November 26, 2013
- November 19, 2013
- November 18, 2013
- November 13, 2013
- November 1, 2013
- October 22, 2013
- October 21, 2013
- October 18, 2013
- October 9, 2013
- September 26, 2013
- September 19, 2013
- September 19, 2013
- September 19, 2013
- September 17, 2013
- September 13, 2013
- September 4, 2013
- August 9, 2013
- July 15, 2013
- July 15, 2013
- July 10, 2013
- June 14, 2013
- May 6, 2013
- April 29, 2013
- April 29, 2013
- April 5, 2013
- April 4, 2013
- April 1, 2013
- March 8, 2013
- January 28, 2013
- January 2, 2013
- December 18, 2012
- November 14, 2012
- November 13, 2012
- November 7, 2012
- October 31, 2012
- October 30, 2012
- October 26, 2012
- September 20, 2012
- July 23, 2012
- July 17, 2012
- July 9, 2012
- May 2, 2012
- March 5, 2012
- February 16, 2012
- February 6, 2012
- January 25, 2012
- January 24, 2012
- November 10, 2011
- April 27, 2011
- April 25, 2011
- March 25, 2010
- February 5, 2010
- July 31, 2009
- July 14, 2008
- May 29, 2008
- January 2, 2008
- February 10, 2006
Events
- March 16, 2023Marrakech, Morocco
- January 21, 2022Hamliton, NY
- November 17, 2021Webinar
- November 9, 2021NYSBA Webinar
- July 22, 2021Globalaw Webinar
- October 21, 2020Virtual
- June 19, 2020Webinar
- February 25, 2020New York, NY
- January 17, 2020Hamilton, New York
- October 22, 2019New York, NY
- March 11, 2019New York City Bar
- November 1, 2018New York, NY
- August 8, 2018New York, New York
- March 6, 2017New York City Bar Association
- March 1, 2016New York City Bar Association
- October 21, 2015
- July 21, 2015The Knowledge Group Website Series
- January 27, 2015The Knowledge Group Website Series
- September 24, 2014Practising Law Institute (PLI)
- May 22, 2014MUPET 2014, Munich Private Equity Training, Germany
- May 7, 2014New York State Society of CPAs (NYSSCPA)
Press Releases
- December 15, 2022
- November 3, 2022
- September 29, 2022
- August 18, 2022
- December 15, 2021
- November 4, 2021
- October 1, 2021
- August 19, 2021
- November 5, 2020
- October 28, 2020
- August 20, 2020
- December 16, 2019
- November 1, 2019
- September 12, 2019
- August 15, 2019
- March 28, 2019
- January 3, 2019
- November 1, 2018
- September 17, 2018
- August 15, 2018
- November 1, 2017
- September 20, 2017
- August 15, 2017
- April 13, 2017
- November 1, 2016
- September 21, 2016
- August 15, 2016
- December 21, 2015
- November 2, 2015
- September 16, 2015
- November 3, 2014
- November 1, 2013
- September 16, 2013
- September 13, 2013
- January 28, 2013
- January 2, 2013
- September 20, 2012
- March 5, 2012
- January 6, 2012
- September 20, 2011
- January 5, 2009
Articles & Alerts
- December 2022
- August 2022
- November 2021
- September 2021
- August 2021
- April 2021
- January 2021
- January 2021
- December 2020
- December 2020
- September 2020
- June 2020
- June 2020
- June 2020
- June 2020
- May 2020
- May 2020
- May 2020
- April 2020
- April 2020
- April 2020
- March 2020
- March 2020
- October 29, 2018
- February 28, 2018
- January 23, 2017
- October 26, 2016
- July 2016
- May 2016
- January 22, 2016
- January 14, 2016
- December 17, 2015
- December 2, 2015
- November 18, 2015
- November 3, 2015
- August 2015
- March 2015
- September 15, 2014
- May 22, 2014
- February 2014
- January 2014
- November 2013
- July 2013
- May 2012
- March 2012
- December 2011
- February 2011
- November 2010
- September 2010
- September 2010
- August 2010
- August 2010
- August 2010
- February 2010
- January 2010
- January 2010
- November 2009
- August 2009
- July 2009
- July 2009
- May 2009
- May 2009
- February 2009
- October 21, 2008
- September 2008
- September 29, 2008
- September 22, 2008
- July 30, 2008
- July 3, 2008
- June 20, 2008
- October 2006
- January 2006
- December 2005
- September 28, 2005
- April 27, 2004
- August 1, 2003
- June 18, 2003
- June 10, 2003
- May 29, 2003
- May 6, 2003
- May 6, 2003
- April 30, 2003
- April 21, 2003
- March 19, 2003
- February 27, 2003
- February 22, 2003
- February 5, 2003
- February 5, 2003
- August 23, 2002
- August 6, 2002
Publications
- Spring 2023Securities Regulation Law Journal (a Thomson Reuters publication)
- Winter 2022Securities Regulation Law Journal (a Thomson Reuters publication)
- March 15, 2023The Legal Intelligencer
- September 22, 2022Harvard Law School Forum on Corporate Governance
- Fall 2022Securities Regulation Law Journal (a Thomson Reuters publication)
- June 23, 2022Insights
- Summer 2022Securities Regulation Law Journal (a Thomson Reuters publication)
- Spring 2022Securities Regulation Law Journal (a Thomson Reuters publication)
- Winter 2021Securities Regulation Law Journal (a Thomson Reuters publication)
- Fall 2021Securities Regulation Law Journal (a Thomson Reuters publication)
- Summer 2021Securities Regulation Law Journal (a Thomson Reuters publication)
- Spring 2021Securities Regulation Law Journal (a Thomson Reuters publication)
- September 30, 2021Insights
- Winter 2020Securities Regulation Law Journal (a Thomson Reuters publication)
- April 9, 2021Law360
- March 11, 2021Harvard Law School Forum on Corporate Governance
- February 1, 2021Harvard Law School Forum on Corporate Governance
- January 12, 2021Harvard Law School Forum on Corporate Governance
- December 13, 2020Harvard Law School Forum on Corporate Governance
- December 11, 2020Harvard Law School Forum on Corporate Governance
- November 6, 2020Harvard Law School Forum on Corporate Governance
- November 5, 2020Harvard Law School Forum on Corporate Governance
- Fall 2020Securities Regulation Law Journal (a Thomson Reuters publication)
- July 29, 2020Harvard Law School Forum on Corporate Governance
- July 22, 2020The New York Law Journal
- Summer 2020Securities Regulation Law Journal (a Thomson Reuters publication)
- Spring 2020Securities Regulation Law Journal (a Thomson Reuters publication)
- Winter 2019Securities Regulation Law Journal (a Thomson Reuters publication)
- Fall 2019Securities Regulation Law Journal (a Thomson Reuters publication)
- Summer 2019Securities Regulation Law Journal (a Thomson Reuters publication)
- October 18, 2019Bloomberg Law
- Spring 2019Securities Regulation Law Journal (a Thomson Reuters publication)
- Fall 2017Securities Regulation Law Journal (a Thomson Reuters publication)
- August 29, 2017Securities Regulation Daily - Wolters Kluwer
- Summer 2017Securities Regulation Law Journal (a Thomson Reuters publication)
- July 4, 2016Bloomberg BNA Securities Regulation & Law Report
- April 26, 2016Law360 (Capital Markets and Securities)
- Winter 2016Securities Regulation Law Journal (a Thomson Reuters publication)
- Winter 2015Securities Regulation Law Journal (a Thomson/Reuters publication)
- Winter 2014Securities Regulation Law Journal
- Fall 2014Securities Regulation Law Journal
- September 2014Securities: Public and Private Offerings
- Summer 2014Securities Regulation Law Journal (Thompson Reuters)
- February 10, 2014Bloomberg BNA Securities Regulation and Law Report
- December 2011Insights: The Corporate & Securities Law Advisor
- Winter 2013 and Spring 2014Securities Regulation Law Journal (Thompson Reuters)
- May 31, 2008Securities Regulation Law Journal
- December 31, 2007Securities Regulation Law Journal
Olshan Real Estate Law Blog
Advertising Law Blog
Securities Law Blog